July 13, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
CHICAGO — In a cohort of patients with difficult-to-control type 2 diabetes, approximately one-quarter had hypercortisolism, according to interim results of part 1 of the CAPTAIN-T2D study presented at ENDO 2026. The results are consistent with those of part 1 of the CATALYST trial, in which, as Healio previously reported, 23.8% of patients with difficult-to-control type 2 diabetes had
July 13, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Early data suggest cortisol may have an impact on hypertension, diabetes, says expert

Expert shares two priorities in hypercortisolism research

Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and…

Marker showed 94% accuracy in patients with indeterminate baseline ACTH levels

Using a continuous glucose monitor improved time in range with no increase in hypoglycemia for people with type 2 diabetes…

Dual testing approach can help in decision making, says researcher